It decreases trafficking and extravasation of cytotoxic T cells, promotes infiltration of Treg cells into the tumor bed [14] and enhances the expression of PD-1 and other inhibitory checkpoints involved in CD8+T cell exhaustion [15]. The gene discussed is CD8A; the disease is neoplasm.